Restless Legs Syndrome
📧 Sign up to get email alerts when something new happens for Restless Legs Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole [Phase 3]
Phase 3 trial comparing immediate-release versus extended-release ropinirole in adults with restless legs syndrome; study completed.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome [Phase 3]
A Phase 3 clinical trial evaluating ropinirole for restless legs syndrome has completed.
-
FDA approval · 2016-10-13FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: Switching From Oral Dopamine Agonists to Rotigotine [Phase 4]
A Phase 4 trial update reports the completion of a study on switching from oral dopamine agonists to Rotigotine for restless legs syndrome, …
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome [Phase 3]
Phase 3 trial update on extended-release ropinirole for restless legs syndrome; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome [Phase 2]
Long-term follow-up results from a Phase 2 study evaluating the safety, efficacy, and tolerability of rotigotine in adolescents with Restles…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) [Phase 3]
A Phase 3 clinical trial evaluating ropinirole for restless legs syndrome has completed.
-
FDA approval · 2016-06-24FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Pramipexole dihydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2016-06-24FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals' pramipexole dihydrochloride as an original generic application, enabling a generic version of pramipe…
-
FDA approval · 2016-06-03FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for NEUPRO (rotigotine) submitted by UCB, Inc.
-
FDA approval · 2016-05-11FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals Inc)
The FDA approved a supplemental application for pramipexole dihydrochloride submitted by ScieGen Pharmaceuticals Inc.
-
FDA approval · 2016-05-10FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark’s supplemental application for pramipexole dihydrochloride, authorizing a generic version of the drug.
-
FDA approval · 2016-04-28FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for pramipexole dihydrochloride from Aurobindo Pharma Limited. The drug is indicated for the treatme…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch [Phase 1]
A Phase 1 study evaluated the irritation and skin sensitization potential of repeat applications of the rotigotine transdermal patch; the tr…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome. [Phase 2]
Phase 2 trial evaluating incobotulinumtoxinA (Xeomin) for relief of restless legs syndrome symptoms has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Sleep Disorders Management, Health and Safety in Police [NA]
Brigham and Women's Hospital sponsored a trial evaluating sleep disorders management and health/safety in police personnel has completed. Th…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Fire Fighter Fatigue Management Program: Operation Fight Fatigue [NA]
This clinical trial update reports that the Fire Fighter Fatigue Management Program: Operation Fight Fatigue study sponsored by Brigham and …
-
FDA approval · 2016-03-14FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for pramipexole dihydrochloride from Alembic Pharmaceuticals Limited. This action approves a sup…
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients [Phase 3]
Phase 3 trial update reports long-term efficacy and safety results for gabapentin enacarbil in Japanese patients with Restless Legs Syndrome…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome [Phase 2]
A Phase 2 clinical trial evaluating probiotics for treating iron deficiency in children with restless legs syndrome has completed.
-
FDA approval · 2016-01-10FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for ropinirole submitted by Alembic Pharmaceuticals Limited (ANDA 202786).
-
FDA approval · 2015-12-11FDA Approved: ROPINIROLE HYDROCHLORIDE — Supplemental Application (SOLCO HEALTHCARE US, LLC)
FDA approved a supplemental application for ropinirole hydrochloride from Solco Healthcare US, LLC.
-
FDA approval · 2015-12-02FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for pramipexole dihydrochloride from Macleods Pharmaceuticals Limited under ANDA 202164.
-
FDA approval · 2015-11-18FDA Approved: ROPINIROLE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA has approved a supplemental application for ropinirole filed by Alembic Pharmaceuticals Limited.
-
FDA approval · 2015-11-17FDA Approved: ROPINIROLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for ropinirole (ropinirole) in the United States. This action approves a supplemental NDA s…